Social Media Press Releases
RSSShowing Press Releases in Category: Products
5/02/2011
MEDIMMUNE TO PRESENT ELEVEN ABSTRACTS ON INFLUENZA AND RESPIRATORY SYNCYTIAL VIRUS AT THE ANNUAL PEDIATRIC ACADEMIC SOCIETIES MEETING
» read more2/01/2011
EUROPEAN COMMISSION APPROVES NASAL SPRAY VACCINE FLUENZ FOR THE PREVENTION OF SEASONAL INFLUENZA IN CHILDREN
» read more10/25/2010
EUROPEAN REGULATOR BACKS NASAL SPRAY VACCINE FLUENZ FOR THE PREVENTION OF SEASONAL INFLUENZA IN CHILDREN
» read more8/20/2009
‘Don’t Play With the Flu’(TM) Campaign to Coach Families on Playing Defense Against Seasonal Flu
» read more6/29/2009
MedImmune Expands Access for Eligible Premature Infants to Receive Synagis(R) at No Cost
» read more5/05/2009
FluMist® Shows Acceptable Safety Profile in Immunocompromised Children, According to New Findings Presented at Pediatric Academic Societies Annual Meeting
» read more5/05/2008
Starting Flu Vaccination in August Could Help Protect Nearly 11 Million More Children During Scheduled Doctors’ Visits
» read more5/05/2008
Efficacy of FluMist(R) in Children Highlighted at Pediatric Academic Societies Meeting
» read more4/28/2008
Fourteen Abstracts Featuring MedImmune’s Influenza and RSV Therapeutic Areas to Be Presented at Pediatric Academic Societies Annual Meeting
» read more4/15/2008
MedImmune Advances Asthma Program with Start of a Phase 2 Trial in Europe and Australia and First U.S.-Based Clinical Trial for Antibody Targeting IL-13
» read more9/19/2007
FDA Approves Expanded Label for FluMist(R) to Include Children Two to Five Years of Age
» read more9/07/2007
